effectiveness donor natural killer cell alloreactivity mismatched hematopoietic transplants
t cells accompany allogeneic hematopoietic grafts treating leukemia enhance engraftment mediate graft-versus-leukemia effect unfortunatety alloreactive t cells also cause graft-versus-host disease gvhd t cell depletion prevents gvhd increases risk graft rejection leukemic relapse human transplants show donor-versus-recipient natural killer nk-cell alloreactivity eliminate leukemia relapse graft rejection protect patients gvhd mice pretransplant infusion alloreactive nk cells obviated need high-intensity conditioning reduced gvhd nk cell alloreactivity may thus provide powerful tool enhancing efficacy safety allogeneic hematopoietic transplantation
